Home - Products - Others - Other Targets - 8-Phenyl-2,6-dibromo-1,3,5,7-tetramethyl BODIPY

8-Phenyl-2,6-dibromo-1,3,5,7-tetramethyl BODIPY

CAS No. 910823-84-6

8-Phenyl-2,6-dibromo-1,3,5,7-tetramethyl BODIPY( —— )

Catalog No. M36552 CAS No. 910823-84-6

8-Phenyl-2,6-dibromo-1,3,5,7-tetramethyl BODIPY can be used in photodynamic therapy.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG 29 In Stock
50MG 35 In Stock
100MG 48 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    8-Phenyl-2,6-dibromo-1,3,5,7-tetramethyl BODIPY
  • Note
    Research use only, not for human use.
  • Brief Description
    8-Phenyl-2,6-dibromo-1,3,5,7-tetramethyl BODIPY can be used in photodynamic therapy.
  • Description
    8-Phenyl-2,6-dibromo-1,3,5,7-tetramethyl BODIPY can be used in photodynamic therapy.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    910823-84-6
  • Formula Weight
    481.97
  • Molecular Formula
    C19H17BBr2F2N2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [F-][B+3]1([F-])[N]=2C(=C(C=3C=CC=CC3)C4=C(C(Br)=C([N-]41)C)C)C(=C(Br)C2C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 4-N-Nonyloxyphenol

    4-N-Nonyloxyphenol (4-nonoxyphenol), a heterogeneous photosensitizer based on kaolinite nanotubes, is a widely used pesticide and endocrine disruptor for the photodegradation of phenol-based pesticides.

  • γ- Bag Cell Peptide

    γ- Bag Cell Peptide

  • DORA-22

    DORA-22 is a dual orexin receptor antagonist, improves mild stress-induced insomnia with minimal effect on memoryDORA-22, a dual orexin receptor antagonist, improves mild stress-induced insomnia with minimal effect on memory.